News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
497,687 Results
Type
Article (23152)
Company Profile (105)
Press Release (474430)
Multimedia
Podcasts (40)
Webinars (4)
Section
Business (148224)
Career Advice (781)
Deals (27207)
Drug Delivery (92)
Drug Development (60162)
Employer Resources (85)
FDA (13951)
Job Trends (10545)
News (255420)
Policy (24877)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (5)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1239)
Accelerated approval (4)
Adcomms (14)
Allergies (72)
Alliances (39326)
ALS (59)
Alzheimer's disease (861)
Antibody-drug conjugate (ADC) (86)
Approvals (13984)
Artificial intelligence (166)
Autoimmune disease (20)
Automation (12)
Bankruptcy (216)
Best Places to Work (8507)
BIOSECURE Act (21)
Biosimilars (108)
Biotechnology (72)
Bladder cancer (40)
Brain cancer (15)
Breast cancer (157)
Cancer (1484)
Cardiovascular disease (109)
Career advice (669)
Career pathing (11)
CAR-T (120)
Cell therapy (354)
Cervical cancer (15)
Clinical research (49860)
Collaboration (624)
Compensation (244)
Complete response letters (20)
COVID-19 (1781)
CRISPR (29)
C-suite (167)
Cystic fibrosis (63)
Data (1626)
Denatured (16)
Depression (23)
Diabetes (214)
Diagnostics (4538)
Digital health (12)
Diversity (1)
Diversity, equity & inclusion (12)
Drug discovery (82)
Drug pricing (70)
Drug shortages (28)
Duchenne muscular dystrophy (73)
Earnings (61911)
Editorial (23)
Employer branding (9)
Employer resources (69)
Events (70864)
Executive appointments (527)
FDA (14981)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (476)
Gene editing (77)
Generative AI (13)
Gene therapy (241)
GLP-1 (537)
Government (3118)
Grass and pollen (4)
Guidances (45)
Healthcare (11470)
Huntington's disease (12)
IgA nephropathy (20)
Immunology and inflammation (84)
Indications (26)
Infectious disease (1883)
Inflammatory bowel disease (95)
Inflation Reduction Act (6)
Influenza (45)
Intellectual property (73)
Interviews (101)
IPO (12311)
IRA (34)
Job creations (2395)
Job search strategy (597)
Kidney cancer (7)
Labor market (14)
Layoffs (311)
Leadership (7)
Legal (4927)
Liver cancer (54)
Lung cancer (237)
Lymphoma (110)
Machine learning (3)
Management (40)
Manufacturing (309)
MASH (39)
Medical device (10917)
Medtech (10921)
Mergers & acquisitions (15349)
Metabolic disorders (495)
Multiple sclerosis (60)
NASH (10)
Neurodegenerative disease (49)
Neuropsychiatric disorders (8)
Neuroscience (1194)
NextGen: Class of 2025 (3855)
Non-profit (1494)
Northern California (1849)
Now hiring (17)
Obesity (259)
Opinion (156)
Ovarian cancer (47)
Pain (57)
Pancreatic cancer (54)
Parkinson's disease (93)
Partnered (13)
Patents (182)
Patient recruitment (73)
Peanut (39)
People (40120)
Pharmaceutical (36)
Pharmacy benefit managers (6)
Phase I (15300)
Phase II (21687)
Phase III (17199)
Pipeline (978)
Policy (106)
Postmarket research (1603)
Preclinical (5919)
Press Release (69)
Prostate cancer (73)
Psychedelics (14)
Radiopharmaceuticals (188)
Rare diseases (252)
Real estate (4385)
Recruiting (33)
Regulatory (18521)
Reports (24)
Research institute (1176)
Resumes & cover letters (93)
Rett syndrome (3)
RNA editing (3)
RSV (28)
Schizophrenia (42)
Series A (84)
Series B (50)
Service/supplier (8)
Sickle cell disease (40)
Southern California (1614)
Special edition (10)
Spinal muscular atrophy (120)
Sponsored (21)
Startups (2532)
State (1)
Stomach cancer (8)
Supply chain (66)
Tariffs (24)
The Weekly (24)
United States (16182)
Vaccines (472)
Venture capitalists (20)
Weight loss (172)
Women's health (22)
Worklife (9)
Date
Today (68)
Last 7 days (318)
Last 30 days (1723)
Last 365 days (24834)
2025 (7025)
2024 (26693)
2023 (30914)
2022 (41087)
2021 (43908)
2020 (41693)
2019 (32758)
2018 (25072)
2017 (26049)
2016 (23972)
2015 (28430)
2014 (20600)
2013 (17151)
2012 (18752)
2011 (19536)
2010 (17102)
Location
Africa (449)
Alabama (40)
Alaska (3)
Arizona (110)
Arkansas (9)
Asia (36499)
Australia (5143)
California (4200)
Canada (1416)
China (518)
Colorado (168)
Connecticut (184)
Delaware (104)
Europe (67004)
Florida (621)
Georgia (166)
Hawaii (1)
Idaho (39)
Illinois (368)
India (22)
Indiana (244)
Iowa (5)
Japan (131)
Kansas (82)
Kentucky (13)
Louisiana (5)
Maine (65)
Maryland (676)
Massachusetts (2985)
Michigan (205)
Minnesota (239)
Mississippi (1)
Missouri (75)
Montana (20)
Nebraska (13)
Nevada (45)
New Hampshire (49)
New Jersey (1420)
New Mexico (23)
New York (1247)
North Carolina (696)
North Dakota (8)
Northern California (1849)
Ohio (152)
Oklahoma (9)
Oregon (26)
Pennsylvania (974)
Puerto Rico (10)
Rhode Island (23)
South America (806)
South Carolina (17)
South Dakota (1)
Southern California (1614)
Tennessee (69)
Texas (584)
Utah (102)
Virginia (110)
Washington D.C. (37)
Washington State (379)
West Virginia (3)
Wisconsin (33)
497,687 Results for "china biologic products".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
AstraZeneca Makes Potential $10B+ China Commitment Despite Political Pressure
The investments come amid an ongoing insurance fraud probe into AstraZeneca’s former China head Leon Wang—and despite mounting pressure from President Trump for pharma companies to re-shore their manufacturing operations.
March 24, 2025
·
2 min read
·
Tristan Manalac
Earnings
Merck’s Gardasil Woes Grow as China Trade War Heats Up
Merck reported a 2% decline in Gardasil sales, after reaching a peak of $8.9 billion in 2023. Now with shipments to China paused, the HPV vaccine faces significant headwinds going into 2025.
February 4, 2025
·
4 min read
·
Annalee Armstrong
Mergers & acquisitions
AstraZeneca Buys FibroGen’s China Unit for $160M as Probes Continue
A year ago, AstraZeneca walked away from the bulk of its roxadustat partnership with FibroGen—though the pharma at the time decided to retain its relationship with the biotech’s China operations.
February 20, 2025
·
2 min read
·
Tristan Manalac
China
The Rise of China Innovation in the Time of Trump
With incoming president Donald Trump threatening a trade war with China, experts told
BioSpace
that the new administration will likely understand why medicines should be treated differently.
January 16, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site
April 18, 2025
·
3 min read
China
Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
January 7, 2025
·
6 min read
·
Annalee Armstrong
VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China
VISEN Pharmaceuticals, an innovative biopharmaceutical company focused on endocrine diseases, announced that the Biologics License Application for Lonapegsomatropin was accepted by the China National Medical Products Administration.
March 7, 2024
·
2 min read
Press Releases
Vyluma Announces Acceptance of Drug Application for NVK002 by China’s National Medical Products Administration (NMPA)
January 29, 2025
·
4 min read
Earnings
Pfizer Eyes Deals up to $15B, With ‘Fruitful’ China Discussions Ongoing
With just one asset in weight loss moving through the clinic, Pfizer targets the space for potential dealmaking, as well as bringing assets over from China.
February 4, 2025
·
4 min read
·
Annalee Armstrong
Government
Lawmakers Seek to Boost US Biotech Sector, Keep China’s Growth in Check
According to analysts at Jefferies, legislation such as the newly proposed bills that aim to streamline regulatory processes would be a positive for the biotech industry.
April 11, 2025
·
2 min read
·
Tristan Manalac
1 of 49,769
Next
